Renal Effects of SGLT2 Inhibitors—From Basic Mechanisms to Clinical Data | American Diabetes Association

Renal Effects of SGLT2 Inhibitors—From Basic Mechanisms to Clinical Data

Speaker: David C Wheeler
Session: Cardiovascular and Renal Protection in Diabetes—Emphasis on SGLT2 Inhibitors and GLP-1 Receptor Agonists
Congress: 79th Scientific Sessions